Albendazole
- Product NDC
- 54505-055
- 11-digit product format
- 545050055
- Labeler code
- 54505
- Product ID
- 54505-055_47d7a0c1-7727-4088-8b5b-90cfea61b4fb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Albendazole
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Lineage Therapeutics Inc
- Application
- NDA020666
- Marketing category
- NDA
- Marketing start
- 2018-09-24
- Marketing end
- 2021-07-31
- Substance
- ALBENDAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anthelmintic [EPC],Cytochrome P450 1A Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 54505-055-22 | 54505005522 | 2 TABLET, FILM COATED in 1 BOTTLE (54505-055-22) | 2018-09-24 | 2021-07-31 | No | No | Current |
| 54505-055-28 | 54505005528 | 28 TABLET, FILM COATED in 1 BOTTLE (54505-055-28) | 2018-09-24 | 2021-07-31 | No | No | Current |